Compare EVO & NTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | NTST |
|---|---|---|
| Founded | 1993 | 2019 |
| Country | Germany | United States |
| Employees | 4766 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | 2020 |
| Metric | EVO | NTST |
|---|---|---|
| Price | $3.50 | $20.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 12 |
| Target Price | $7.00 | ★ $20.42 |
| AVG Volume (30 Days) | 138.6K | ★ 1.6M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.32% |
| EPS Growth | N/A | ★ 150.00 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $195,006,000.00 |
| Revenue This Year | N/A | $15.47 |
| Revenue Next Year | $7.13 | $14.49 |
| P/E Ratio | ★ N/A | $254.88 |
| Revenue Growth | N/A | ★ 19.79 |
| 52 Week Low | $2.84 | $14.00 |
| 52 Week High | $4.80 | $20.55 |
| Indicator | EVO | NTST |
|---|---|---|
| Relative Strength Index (RSI) | 49.94 | 66.00 |
| Support Level | $3.52 | $19.77 |
| Resistance Level | $3.67 | $20.55 |
| Average True Range (ATR) | 0.09 | 0.47 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 36.36 | 82.35 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.